Cancer Biology & Medicine: 23 (8)

August 15, 2026; Volume 23,Issue 8

Perspective

Open Access
Less is more: patients with cervical cancer benefit from de-escalated chemotherapy plus immuno-targeted therapies
Bohao Zheng, Dian Fan and Shengtao Zhou

Cancer Biology & Medicine August 2026, 23 (8) 1051-1056; DOI: https://doi.org/10.20892/j.issn.2095-3941.2026.0139

Open Access
Harnessing the microbiome: a new frontier in lung cancer immunotherapy
Kexin Feng, Jun Wang, Shuai Wang, Zewen Sun, Mantang Qiu, Zuli Zhou, Yun Li and Kezhong Chen

Cancer Biology & Medicine August 2026, 23 (8) 1057-1086; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0177
Open Access
Tumor microenvironment-driven natural killer cell diversity: mechanisms and therapeutic opportunities
Yue Duan, Mingzhen Zhou, Xingxian Guo, Tianyu Cao, Yuanyuan Lu and Xiaodi Zhao

Cancer Biology & Medicine August 2026, 23 (8) 1087-1107; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0829
Open Access
Surgery-centered integrated strategies for personalized hepatocellular carcinoma care
Yuhan Cui, Zuchao Du, Jiahao Xu, Lihui Gu, Jiaqi Du, Mingda Wang and Tian Yang

Cancer Biology & Medicine August 2026, 23 (8) 1108-1127; DOI: https://doi.org/10.20892/j.issn.2095-3941.2026.0045

Open Access
Exosomal EPHA2 transfers metastatic potential by stabilizing TGF-βRI and activating the TGF-β/SMAD3 signaling pathway in breast cancer
Liming Liu, Yichu Zhang, Xiaoxue Li, Yueni Mo, Lanlan Song, Yidi Jia, Luoming Zhang, Wei Zhou, He Zhang, Hui Guo, Zhiyong Wang, Yanfen Cui, Fei Zhang and Ruifang Niu

Cancer Biology & Medicine August 2026, 23 (8) 1128-1155; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0440
Open Access
Efficacy and safety of first-line osimertinib in Chinese patients with EGFR-mutated advanced non-small cell lung cancer: a prospective, multicenter, non-interventional study (FLOURISH)
Lisha Shen, Dongqing Lv, Ke-Jing Tang, Jun Zhao, Dan Zhu, Yanqiu Zhao, Ke Wang, Yan Wang, Zhigang Cai, Ligang Xing, Ke Xie, Jiuwei Cui, Lin Mu, Chao Cao, Liren Ding, Peifeng Chen, Jun Liang, Yongmin Ding, Liqin Lu, Jiliang Zhang, Xinmin Yu, Li Chen, Jing Zheng, Jianya Zhou and Jianying Zhou

Cancer Biology & Medicine August 2026, 23 (8) 1156-1166; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0566
Open Access
Myeloid cell reprogramming combined with zoledronic acid effectively suppresses bone metastasis
Yuting Luo, Yiran Cai, Zizheng Jiang, Ke Zheng, Shiji Ren, Lixia Yu, Baorui Liu, Tao Shi and Jia Wei

Cancer Biology & Medicine August 2026, 23 (8) 1167-1192; DOI: https://doi.org/10.20892/j.issn.2095-3941.2026.0168

Open Access
Dietary restriction during active cancer therapy is associated with improved treatment response: a systematic review and meta-analysis
Kajal Agrawal, Dominic Shao Yong Goh, Ee Chern Ng, Shyn Yi Tan, Carlos Cifuentes-González, Jason Xing Kang, William K. K. Wu, Rashid N. S. Lui, Rupesh Agrawal, Yusuf Ali and Sunny H. Wong

Cancer Biology & Medicine August 2026, 23 (8) 1193-1197; DOI: https://doi.org/10.20892/j.issn.2095-3941.2025.0841
Open Access
Unveiling molecular incomplete response (mIR) via ultra-deep NGS: a novel concept contrasting pathologic complete response (pCR) in occult lymph node micrometastases of non-small cell lung cancer
Meng Lu, Ran Zhang, Haidi Xu, Bingsheng Sun, Peng Chen, Xuan Gao, Meiming Zhong and Jian You

Cancer Biology & Medicine August 2026, 23 (8) 1198-1203; DOI: https://doi.org/10.20892/j.issn.2095-3941.2026.0171